A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
via Google News
The Latest on: Antimicrobial therapy
- Global experts to address antimicrobial resistance challenge at IIT KGP on December 17, 2018 at 9:31 pm
This would reduce drug abuse and misuse, thus bringing down the adverse effect on future antimicrobial therapy," opined Anindya S Ghosh, faculty at IIT Kharagpur and convenor of handling and co ... […]
- Treatment bundle leads to ‘dramatic improvement’ in UTI management on December 17, 2018 at 3:13 am
“Despite having no clinical benefit, antimicrobial therapy is frequently provided to patients with AB in an inpatient setting,” MacLaggan and colleagues wrote. “Inappropriate provision of antimicrobia... […]
- Antimicrobial Use and Antimicrobial Resistance FAQ on December 9, 2018 at 4:37 am
... of antimicrobial resistance in organisms that infect animals because it may compromise the effectiveness of antimicrobial therapy for animal diseases and make them harder to treat. Antimicrobials ... […]
- One Health series: The politics of antimicrobial resistance on December 8, 2018 at 6:27 am
“We need to develop rapid diagnostics, antibiotic alternatives, particularly phage therapy. We need state-of-the-art sanitation ... are embracing a One Health approach to addressing antimicrobial resi... […]
- Aridis to Start Phase 1/2a Trial for Inhalable Antibacterial Therapy AR-501 in CF Patients on December 7, 2018 at 5:58 am
These are expected to support and expedite the therapy’s development and regulatory review ... In addition, it is a broad-spectrum antimicrobial agent “with a low propensity for developing drug resist... […]
- 5 key strategies to mitigate the effect of antimicrobial resistance on December 5, 2018 at 3:22 pm
However, if institutions place greater emphasis on strategies to fight this resistance, such as ensuring appropriate antimicrobial therapy and developing robust antibiotic stewardship initiatives, hea... […]
- GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2 on December 5, 2018 at 10:03 am
Delayed antimicrobial therapy significantly increases mortality in high-risk infections with a particularly strong association with septic shock. Therefore, antimicrobial agents are often injudiciousl... […]
- ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy on November 13, 2018 at 12:59 pm
Before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital—whether at home, a doctor's office or a skilled nursing facility—an infectious diseases (ID) specialist ... […]
- Bacteriophages: a promising approach to fighting antibiotic-resistant bacteria on October 9, 2018 at 12:05 pm
In 2012, I wrote about bacteriophage therapy as one possible solution to worsening antimicrobial resistance, a major threat to human and animal health. Much has happened since then to highlight the an... […]
via Bing News